Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer

52Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Background: In breast cancer, there is an inverse relationship between HER2/neu overexpression and receptors for estrogen (ER) or progesterone (PR). Some clinical observations such as the age-related association between hormone receptors and tumour grade, which predicts HER2/neu overexpression, suggest an age-related relationship. Patients and methods: Our study population consisted of 1362 consecutive women receiving primary surgery for non-metastatic invasive breast cancer. We compared the relationship between both hormone receptors and HER2/neu overexpression in different age groups taking other tumour characteristics into account. Results: In a multivariate model, considering the overall group, a negative ER, a negative PR and a high tumour grade were predictive for HER2/neu overexpression (P <0.001). Considering 246 women aged ≤45 years, the only predictor for HER2/neu overexpression in this age category was a high tumour grade (P = 0.003). Considering the 1116 women aged >45 years, ER (P = 0.001), PR (P = 0.001) and tumour grade (P <0.001) were associated with HER2/neu (P <0.001). Conclusion: Our findings indicate that the association between ER, PR and HER2/neu overexpression varies with age. The hormone receptors are not an independent predictor for the HER2/neu status in young women while they are in elder patients. © 2005 European Society for Medical Oncology.

References Powered by Scopus

Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene

10695Citations
N/AReaders
Get full text

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

6640Citations
N/AReaders
Get full text

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial

1054Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US

143Citations
N/AReaders
Get full text

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors

92Citations
N/AReaders
Get full text

A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China

82Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Huang, H. J., Neven, P., Drijkoningen, M., Paridaens, R., Wildiers, H., Van Limbergen, E., … Christiaens, M. R. (2005). Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer. Annals of Oncology, 16(11), 1755–1761. https://doi.org/10.1093/annonc/mdi364

Readers over time

‘11‘13‘16‘17‘18‘20‘21‘22‘24‘2501234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

60%

Researcher 3

30%

Professor / Associate Prof. 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

62%

Agricultural and Biological Sciences 2

15%

Biochemistry, Genetics and Molecular Bi... 2

15%

Business, Management and Accounting 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0